PL2570415T3 - N-[4-(1H-pirazolo[3,4-b]pirazyn-6-ylo)-fenylo]-sulfonamidy i ich zastosowanie jako farmaceutyki - Google Patents

N-[4-(1H-pirazolo[3,4-b]pirazyn-6-ylo)-fenylo]-sulfonamidy i ich zastosowanie jako farmaceutyki

Info

Publication number
PL2570415T3
PL2570415T3 PL11306179T PL11306179T PL2570415T3 PL 2570415 T3 PL2570415 T3 PL 2570415T3 PL 11306179 T PL11306179 T PL 11306179T PL 11306179 T PL11306179 T PL 11306179T PL 2570415 T3 PL2570415 T3 PL 2570415T3
Authority
PL
Poland
Prior art keywords
pyrazin
pyrazolo
sulfonamides
pharmaceuticals
phenyl
Prior art date
Application number
PL11306179T
Other languages
English (en)
Inventor
Marc Nazaré
Nis Halland
Friedemann Schmidt
Tilo Weiss
Uwe Dietz
Armin Hofmeister
Jean-Christophe Carry
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL2570415T3 publication Critical patent/PL2570415T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL11306179T 2011-09-19 2011-09-19 N-[4-(1H-pirazolo[3,4-b]pirazyn-6-ylo)-fenylo]-sulfonamidy i ich zastosowanie jako farmaceutyki PL2570415T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11306179.0A EP2570415B1 (en) 2011-09-19 2011-09-19 N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
PL2570415T3 true PL2570415T3 (pl) 2016-01-29

Family

ID=46875813

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11306179T PL2570415T3 (pl) 2011-09-19 2011-09-19 N-[4-(1H-pirazolo[3,4-b]pirazyn-6-ylo)-fenylo]-sulfonamidy i ich zastosowanie jako farmaceutyki

Country Status (17)

Country Link
US (1) US9174993B2 (pl)
EP (2) EP2570415B1 (pl)
AR (1) AR087907A1 (pl)
BR (1) BR112014006207A2 (pl)
CY (1) CY1117006T1 (pl)
DK (1) DK2570415T3 (pl)
EA (1) EA024295B1 (pl)
ES (2) ES2552836T3 (pl)
HR (1) HRP20151183T1 (pl)
HU (1) HUE026072T2 (pl)
MX (1) MX342869B (pl)
MY (1) MY179987A (pl)
PL (1) PL2570415T3 (pl)
PT (1) PT2570415E (pl)
SI (1) SI2570415T1 (pl)
TW (1) TWI577679B (pl)
WO (1) WO2013041502A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017373758B2 (en) * 2016-12-07 2021-12-16 Orimos Therapeutics Co., Ltd. Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof
EP3585371B1 (en) * 2017-02-24 2024-07-10 Indiana University Research and Technology Corporation Methods of inhibiting serum glucocorticoid induced kinase 1 (sgk1) as a treatment for salt and water balance diseases
MX2021015511A (es) 2019-06-14 2022-01-31 Janssen Pharmaceutica Nv Carbamatos de pirazina y sus usos como moduladores del receptor glun2b.
CA3143103A1 (en) 2019-06-14 2020-12-17 Janssen Pharmaceutica Nv Pyridine carbamates and their use as glun2b receptor modulators
TW202112774A (zh) 2019-06-14 2021-04-01 比利時商健生藥品公司 經取代之吡唑并-吡啶醯胺及其作為glun2b受體調節劑之用途
JP7667097B2 (ja) 2019-06-14 2025-04-22 ヤンセン ファーマシューティカ エヌ.ベー. 置換ピラゾロ-ピリジンアミド及びglun2b受容体調節因子としてのその使用
BR112021025141A2 (pt) 2019-06-14 2022-01-25 Janssen Pharmaceutica Nv Pirazolo-piridinas heteroaromáticas substituídas e seu uso como moduladores do receptor glun2b
CN114008052A (zh) * 2019-06-14 2022-02-01 詹森药业有限公司 取代的吡唑并-吡嗪以及它们作为GluN2B受体调节剂的用途
WO2024015055A1 (en) * 2022-07-13 2024-01-18 Thryv Therapeutics Inc. Pyrazolo[3,4-d]pyrimidin-6-yl-sulfonamide derivatives for the inhibition of sgk-1 and treatment of cancer
EP4665733A1 (en) * 2023-02-14 2025-12-24 Bristol-Myers Squibb Company Amino-substituted pyrrolotriazine derivatives as inhibitors of sgk1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6690240B2 (en) 2002-01-10 2004-02-10 Cirrus Logic, Inc. Low-jitter loop filter for a phase-locked loop system
CA2537916A1 (en) 2003-09-03 2005-03-31 Neurogen Corporation 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
DE102004059781A1 (de) 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
DE102005015255A1 (de) 2005-04-04 2006-10-05 Merck Patent Gmbh Acylhydrazide
DE102006043443A1 (de) 2006-09-15 2008-03-27 Bayer Healthcare Ag Neue aza-bicyclische Verbindungen und ihre Verwendung
DE102007002717A1 (de) 2007-01-18 2008-07-24 Merck Patent Gmbh Heterocyclische Indazolderivate
US20130072493A1 (en) 2011-09-19 2013-03-21 Sanofi N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS
KR20140064975A (ko) 2011-09-19 2014-05-28 사노피 N­[4­(1H­피라졸로[3,4­b]피라진­6­일)­페닐]­설폰아미드 및 약제로서의 이의 용도

Also Published As

Publication number Publication date
US9174993B2 (en) 2015-11-03
EP2758399A1 (en) 2014-07-30
US20140357640A1 (en) 2014-12-04
TW201329079A (zh) 2013-07-16
DK2570415T3 (en) 2015-11-23
ES2552836T3 (es) 2015-12-02
EA024295B1 (ru) 2016-09-30
EP2570415B1 (en) 2015-08-26
HUE026072T2 (en) 2016-05-30
SI2570415T1 (sl) 2015-12-31
AR087907A1 (es) 2014-04-23
TWI577679B (zh) 2017-04-11
MX2014002736A (es) 2014-05-01
EA201490662A1 (ru) 2014-07-30
EP2758399B1 (en) 2017-11-15
EP2570415A1 (en) 2013-03-20
CY1117006T1 (el) 2017-04-05
MX342869B (es) 2016-10-17
WO2013041502A1 (en) 2013-03-28
PT2570415E (pt) 2015-11-23
HRP20151183T1 (hr) 2015-12-04
EP2570415A8 (en) 2013-05-22
ES2659551T3 (es) 2018-03-16
MY179987A (en) 2020-11-19
BR112014006207A2 (pt) 2017-04-11

Similar Documents

Publication Publication Date Title
PT2570415E (pt) N-[4-(1h-pirazolo[3,4-b]pirazin-6-il)-fenil]-sulfonamidas e a sua utilização como fármacos
AP2014007541A0 (en) Substituted annellated pyrimidine and the use thereof
AU2012300844A1 (en) Substituted annellated pyrimidine and the use thereof
IL232906A (en) Pyrazolopyridine derivatives, a process for their preparation and medical use
ZA201404294B (en) Substituted 1,2,5-oxadiazole compounds and their use as herbicides
IL232279A0 (en) Converted 5,2,1-oxadiazole compounds and their use as herbicides ii
IL250370A0 (en) Propionic acid derivatives substituted with heteroaroylamino in position 3 and their use as pharmaceuticals
IL249826A0 (en) Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations
IL231097A0 (en) N-[4-(h 1 -pyrazolo[-b3,4]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
PL2648715T3 (pl) Mieszaniny karnozyny-kwasu hialuronowego i ich zastosowanie
AP2014007616A0 (en) Agrochemical formulation and use thereof
IL232809A (en) Carboxamides are preserved in position 2 isothiazolopyridine-2-carboxamides and used as drugs
IL231096A (en) Theses are converted into 2- (novel-6-Iloxy) and used as pharmaceutical preparations
PH12014500542A1 (en) Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
Lee et al. Model Kits and Spatial Ability
GB201122368D0 (en) Process, use and product